211 related articles for article (PubMed ID: 21816904)
21. The hallmarks of CDKN1C (p57, KIP2) in cancer.
Kavanagh E; Joseph B
Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of
Rossi MN; Andresini O; Matteini F; Maione R
Front Biosci (Landmark Ed); 2018 Jan; 23(1):83-108. PubMed ID: 28930539
[TBL] [Abstract][Full Text] [Related]
23. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
25. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
26. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
[TBL] [Abstract][Full Text] [Related]
28. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
29. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
[TBL] [Abstract][Full Text] [Related]
31. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.
Bilodeau S; Roussel-Gervais A; Drouin J
Mol Cell Biol; 2009 Apr; 29(7):1895-908. PubMed ID: 19139274
[TBL] [Abstract][Full Text] [Related]
32. p57 kip2's role beyond Schwann cell cycle control.
Heinen A; Kremer D; Hartung HP; Küry P
Cell Cycle; 2008 Sep; 7(18):2781-6. PubMed ID: 18769142
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
[TBL] [Abstract][Full Text] [Related]
35. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
Fan GK; Xu F; Yang B; Fujieda S
Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
[TBL] [Abstract][Full Text] [Related]
36. A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord.
Gui H; Li S; Matise MP
Dev Biol; 2007 Jan; 301(1):14-26. PubMed ID: 17123502
[TBL] [Abstract][Full Text] [Related]
37. High Dosage Lithium Treatment Induces DNA Damage and p57
Stampone E; Bencivenga D; Barone C; Aulitto A; Verace F; Della Ragione F; Borriello A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050593
[TBL] [Abstract][Full Text] [Related]
38. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Int J Mol Med; 2002 Apr; 9(4):373-6. PubMed ID: 11891530
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
40. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
